Product Code: GVR-4-68040-425-5
Laryngoscopes Blades And Handles Market Growth & Trends:
The global laryngoscopes blades and handles market size is expected to reach USD 1.72 billion by 2030, growing at a CAGR of 9.12% from 2024 to 2030, according to a new report by Grand View Research, Inc. This robust growth trajectory is driven by several key factors. The increasing prevalence of respiratory disorders and chronic diseases requiring airway management is a major driver. Conditions such as chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea necessitate frequent use of laryngoscopes for intubation and airway management, fueling demand for these medical devices. According to the American Lung Association, 11.7 million people which is 4.6% of adults, reported a diagnosis of COPD (chronic obstructive pulmonary disease), chronic bronchitis, or emphysema in 2022. Additionally, the aging global population, more susceptible to respiratory issues, further amplifies the need for advanced laryngoscopy equipment.
Recent developments in the field have also played a pivotal role in market growth. Technological advancements have significantly enhanced the functionality and effectiveness of laryngoscopes. Innovations such as video laryngoscopes, which provide real-time visualization of the airway, have improved the precision of intubation procedures and reduced complications. These advancements are increasingly being adopted in both emergency and elective surgeries, contributing to the rising demand for high-quality laryngoscope blades and handles. Furthermore, the integration of artificial intelligence (AI) and digital imaging into laryngoscopy devices is enabling more accurate and efficient diagnoses, thereby enhancing their appeal to healthcare providers. Moreover, the rise in outpatient and minimally invasive procedures has shifted the demand towards portable and versatile laryngoscope systems. This trend is supported by advancements in battery technology and the miniaturization of electronic components, making it easier for healthcare providers to use these devices in various settings, from hospital operating rooms to emergency medical services.
Laryngoscopes Blades And Handles Market Report Highlights:
- Based on type, the rigid laryngoscopes segment held the largest share of 58.8% in 2023. This dominance is driven by several factors including clinical efficacy, widespread usage, and ongoing technological enhancements.
- Based on end use, the hospitals segment held the largest share of more than 60.0% in 2023. This growth is attributed to the high prevalence of complex medical conditions, advancements in healthcare technology, and the increasing demand for specialized medical procedures.
- In September 2023, Penlon introduced the Diamond Video Laryngoscope, a cutting-edge tool for airway management. The ergonomic handle offers up to 4 hours of use and features an intuitive interface and a high-capacity rechargeable battery. Available with single-use Macintosh-style blades for both pediatric and adult patients, it also includes a specialized blade for challenging intubations.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Type
- 1.2.2. End Use
- 1.2.3. Regional scope
- 1.2.4. Estimates and forecast timeline.
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database.
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.4.5.1. Data for primary interviews in North America
- 1.4.5.2. Data for primary interviews in Europe
- 1.4.5.3. Data for primary interviews in Asia Pacific
- 1.4.5.4. Data for primary interviews in Latin America
- 1.4.5.5. Data for Primary interviews in MEA
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Type Outlook
- 2.2.2. End Use Outlook
- 2.2.3. Regional Outlook
- 2.3. Competitive Insights
Chapter 3. Laryngoscopes Blades and Handles Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Increasing Prevalence of Respiratory Diseases
- 3.2.1.2. Technological Advancement
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Stringent Regulation and Approvals
- 3.2.2.2. High Cost of Devices
- 3.3. Laryngoscopes Blades and Handles Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Supplier Power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
- 3.3.3. Pipeline Analysis
Chapter 4. Laryngoscopes Blades and Handles Market: Type Estimates & Trend Analysis
- 4.1. Laryngoscopes Blades and Handles Market: Type Dashboard
- 4.2. Laryngoscopes Blades and Handles Market: Type Movement Analysis
- 4.3. Laryngoscopes Blades and Handles Market by Type, Revenue (USD Million)
- 4.4. Rigid Laryngoscopes
- 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 4.5. Flexible Laryngoscopes
- 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Laryngoscopes Blades and Handles Market: End Use Estimates & Trend Analysis
- 5.1. Laryngoscopes Blades and Handles Market: End Use Dashboard
- 5.2. Laryngoscopes Blades and Handles Market: End Use Movement Analysis
- 5.3. Laryngoscopes Blades and Handles Market by End Use, Revenue (USD Million)
- 5.4. Hospitals
- 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 5.5. Ambulatory Surgery Centers
- 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 5.6. Specialty Clinics
- 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 5.7. Others
- 5.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Laryngoscopes Blades and Handles Market: Regional Estimates & Trend Analysis, By Type, and By End Use.
- 6.1. Regional Dashboard
- 6.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
- 6.3. North America
- 6.3.1. U.S.
- 6.3.1.1. Key country dynamics
- 6.3.1.2. Regulatory framework/ reimbursement structure
- 6.3.1.3. Competitive scenario
- 6.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 6.3.2. Canada
- 6.3.2.1. Key country dynamics
- 6.3.2.2. Regulatory framework/ reimbursement structure
- 6.3.2.3. Competitive scenario
- 6.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 6.3.3. Mexico
- 6.3.3.1. Key country dynamics
- 6.3.3.2. Regulatory framework/ reimbursement structure
- 6.3.3.3. Competitive scenario
- 6.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4. Europe
- 6.4.1. UK
- 6.4.1.1. Key country dynamics
- 6.4.1.2. Regulatory framework/ reimbursement structure
- 6.4.1.3. Competitive scenario
- 6.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.2. Germany
- 6.4.2.1. Key country dynamics
- 6.4.2.2. Regulatory framework/ reimbursement structure
- 6.4.2.3. Competitive scenario
- 6.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.3. France
- 6.4.3.1. Key country dynamics
- 6.4.3.2. Regulatory framework/ reimbursement structure
- 6.4.3.3. Competitive scenario
- 6.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.4. Italy
- 6.4.4.1. Key country dynamics
- 6.4.4.2. Regulatory framework/ reimbursement structure
- 6.4.4.3. Competitive scenario
- 6.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.5. Spain
- 6.4.5.1. Key country dynamics
- 6.4.5.2. Regulatory framework/ reimbursement structure
- 6.4.5.3. Competitive scenario
- 6.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.6. Norway
- 6.4.6.1. Key country dynamics
- 6.4.6.2. Regulatory framework/ reimbursement structure
- 6.4.6.3. Competitive scenario
- 6.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.7. Sweden
- 6.4.7.1. Key country dynamics
- 6.4.7.2. Regulatory framework/ reimbursement structure
- 6.4.7.3. Competitive scenario
- 6.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.8. Denmark
- 6.4.8.1. Key country dynamics
- 6.4.8.2. Regulatory framework/ reimbursement structure
- 6.4.8.3. Competitive scenario
- 6.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5. Asia Pacific
- 6.5.1. Japan
- 6.5.1.1. Key country dynamics
- 6.5.1.2. Regulatory framework/ reimbursement structure
- 6.5.1.3. Competitive scenario
- 6.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5.2. China
- 6.5.2.1. Key country dynamics
- 6.5.2.2. Regulatory framework/ reimbursement structure
- 6.5.2.3. Competitive scenario
- 6.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5.3. India
- 6.5.3.1. Key country dynamics
- 6.5.3.2. Regulatory framework/ reimbursement structure
- 6.5.3.3. Competitive scenario
- 6.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5.4. Australia
- 6.5.4.1. Key country dynamics
- 6.5.4.2. Regulatory framework/ reimbursement structure
- 6.5.4.3. Competitive scenario
- 6.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5.5. South Korea
- 6.5.5.1. Key country dynamics
- 6.5.5.2. Regulatory framework/ reimbursement structure
- 6.5.5.3. Competitive scenario
- 6.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5.6. Singapore
- 6.5.6.1. Key country dynamics
- 6.5.6.2. Regulatory framework/ reimbursement structure
- 6.5.6.3. Competitive scenario
- 6.5.6.4. Singapore market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6. Latin America
- 6.6.1. Brazil
- 6.6.1.1. Key country dynamics
- 6.6.1.2. Regulatory framework/ reimbursement structure
- 6.6.1.3. Competitive scenario
- 6.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6.2. Argentina
- 6.6.2.1. Key country dynamics
- 6.6.2.2. Regulatory framework/ reimbursement structure
- 6.6.2.3. Competitive scenario
- 6.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7. MEA
- 6.7.1. South Africa
- 6.7.1.1. Key country dynamics
- 6.7.1.2. Regulatory framework/ reimbursement structure
- 6.7.1.3. Competitive scenario
- 6.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7.2. Saudi Arabia
- 6.7.2.1. Key country dynamics
- 6.7.2.2. Regulatory framework/ reimbursement structure
- 6.7.2.3. Competitive scenario
- 6.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7.3. UAE
- 6.7.3.1. Key country dynamics
- 6.7.3.2. Regulatory framework/ reimbursement structure
- 6.7.3.3. Competitive scenario
- 6.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7.4. Kuwait
- 6.7.4.1. Key country dynamics
- 6.7.4.2. Regulatory framework/ reimbursement structure
- 6.7.4.3. Competitive scenario
- 6.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
- 7.1. Company/Competition Categorization
- 7.2. Vendor Landscape
- 7.2.1. List of key distributors and channel partners
- 7.2.2. Key customers
- 7.2.3. Key company market share analysis, 2023
- 7.3. Company Profiles
- 7.3.1. Teleflex Incorporated
- 7.3.1.1. Company overview
- 7.3.1.2. Financial performance
- 7.3.1.3. Product benchmarking
- 7.3.1.4. Strategic initiatives
- 7.3.2. Medline Industries, Inc.
- 7.3.2.1. Company overview
- 7.3.2.2. Financial performance
- 7.3.2.3. Product benchmarking
- 7.3.2.4. Strategic initiatives
- 7.3.3. Medtronic
- 7.3.3.1. Company overview
- 7.3.3.2. Financial performance
- 7.3.3.3. Product benchmarking
- 7.3.3.4. Strategic initiatives
- 7.3.4. Olympus Corporation
- 7.3.4.1. Company overview
- 7.3.4.2. Financial performance
- 7.3.4.3. Product benchmarking
- 7.3.4.4. Strategic initiatives
- 7.3.5. Stryker
- 7.3.5.1. Company overview
- 7.3.5.2. Financial performance
- 7.3.5.3. Product benchmarking
- 7.3.5.4. Strategic initiatives
- 7.3.6. Hartwell Medical LLC
- 7.3.6.1. Company overview
- 7.3.6.2. Financial performance
- 7.3.6.3. Product benchmarking
- 7.3.6.4. Strategic initiatives
- 7.3.7. American Diagnostic Corporation
- 7.3.7.1. Company overview
- 7.3.7.2. Financial performance
- 7.3.7.3. Product benchmarking
- 7.3.7.4. Strategic initiatives
- 7.3.8. KARL STORZ GmbH & Co. KG
- 7.3.8.1. Company overview
- 7.3.8.2. Financial performance
- 7.3.8.3. Product benchmarking
- 7.3.8.4. Strategic initiatives